Berry Street Capital Management LLP Argenx Se Transaction History

Berry Street Capital Management LLP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$269.58 - $378.88 $6.74 Million - $9.47 Million	-25,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$254.45 - $351.06 $3.82 Million - $5.27 Million	15,000 Added 150.0%	25,000 $7.88 Million
Q4 2021 Feb 10, 2022	BUY	$272.01 - $353.03 $2.72 Million - $3.53 Million	10,000 New	10,000 $3.5 Million

371

31.4M

303K

429K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $29.7B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Berry Street Capital Management LLP, based on Form 13F filings with the SEC.

Stay updated on Berry Street Capital Management LLP with notifications on news.